These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5820666)

  • 1. Structural requirements for binding of bradykinin to antibody. 3. The effect of carrier on antibody specificity.
    Fischer J; Spragg J; Talamo RC; Pierce JV; Suzuki K; Austen KF; Haber E
    Biochemistry; 1969 Sep; 8(9):3750-7. PubMed ID: 5820666
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural requirements for binding of bradykinin to antibody. II. Studies with bradykinin fragments.
    Spragg J; Talamo RC; Suzuki K; Appelbaum DM; Austen KF; Haber E
    Biochemistry; 1968 Nov; 7(11):4086-9. PubMed ID: 5749176
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody to bradykinin: effect of carrier and method of coupling on specificity and affinity.
    Talamo RC; Haber E; Austen KF
    J Immunol; 1968 Aug; 101(2):333-41. PubMed ID: 4970069
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of human urinary kinin levels by radioimmunoassay using a tyrosine analogue of bradykinin.
    Mashford ML; Roberts ML
    Biochem Pharmacol; 1971 May; 20(5):969-73. PubMed ID: 5168394
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural requirements for binding to antibody of sequence variants of bradykinin.
    Spragg J; Schröder E; Stewart JM; Austen KF; Haber E
    Biochemistry; 1967 Dec; 6(12):3933-41. PubMed ID: 5299782
    [No Abstract]   [Full Text] [Related]  

  • 6. The substrate recognition site of collagen proline hydroxylase: the hydroxylation of -X-Pro-Gly- sequences in bradykinin analogs and other peptides.
    McGee JO; Rhoads RE; Udenfriend S
    Arch Biochem Biophys; 1971 May; 144(1):343-51. PubMed ID: 5117532
    [No Abstract]   [Full Text] [Related]  

  • 7. A general method for the specific isolation of peptides containing modified residues, using insoluble antibody columns.
    Wilchek M; Bocchini V; Becker M; Givol D
    Biochemistry; 1971 Jul; 10(15):2828-34. PubMed ID: 5165492
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of substituent constants in the quantitative treatment of hapten-antibody interaction.
    Kutter E; Hansch C
    Arch Biochem Biophys; 1969 Dec; 135(1):126-35. PubMed ID: 5391470
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralization by an antibody of some vascular actions of bradykinin.
    Martin CA; Mashford ML; Roberts ML
    Biochem Pharmacol; 1971 Nov; 20(11):3179-84. PubMed ID: 4108901
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of arginine in the active sites of antibodies.
    Grossberg AL; Pressman D
    Biochemistry; 1968 Jan; 7(1):272-9. PubMed ID: 4098210
    [No Abstract]   [Full Text] [Related]  

  • 11. Combining sites of IgG and IgM antibodies of poly-D-alanyl specificity.
    Haimovich J; Schechter I; Sela M
    Eur J Biochem; 1969 Feb; 7(4):537-43. PubMed ID: 5813322
    [No Abstract]   [Full Text] [Related]  

  • 12. Proof of independency of two antigenic sites in egg white lysozyme.
    Fujio H; Imanishi M; Nishioka K; Amano T
    Biken J; 1968 Sep; 11(3):219-23. PubMed ID: 5721303
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoassay of bradykinin: chemical modification to enable use of radioactive iodine.
    Goodfriend TL; Ball DL
    J Lab Clin Med; 1969 Mar; 73(3):501-11. PubMed ID: 5766195
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between chemical structure and antigenicity of angiotensin analogues.
    Vallotton MB
    Immunochemistry; 1970 Jun; 7(6):529-42. PubMed ID: 4320828
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspects of bradykinin radioimmunoassay.
    Odya CE; Goodfriend TL; Stewart JM; Peña C
    J Immunol Methods; 1978; 19(2-3):243-57. PubMed ID: 624845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the immunochemical specificity of some antibodies to human gastrin. I.
    McGuigan JE
    Gastroenterology; 1969 Mar; 56(3):429-38. PubMed ID: 5766901
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of epinephrine, amino acids and albumin on the measurement of insulin by radioimmunoassay.
    Szabo O; Mahler RJ
    Horm Metab Res; 1970 May; 2(3):125-30. PubMed ID: 5535405
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioimmunoassay of human fibrinopeptide A.
    Nossel HL; Younger LR; Wilner GD; Procupez T; Canfield RE; Butler VP
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2350-3. PubMed ID: 5289869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation and specificity of antibody to thyrotropin releasing hormone.
    Bassiri RM; Utiger RD
    Endocrinology; 1972 Mar; 90(3):722-7. PubMed ID: 4621569
    [No Abstract]   [Full Text] [Related]  

  • 20. Antivasopressin antibody. Characterization of high-affinity rabbit antibody with limited association constant heterogeneity.
    Wu WH; Rockey JH
    Biochemistry; 1969 Jul; 8(7):2719-28. PubMed ID: 5808330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.